MedPath

Intra-operative real-time diagnostic probe for suspicious legions using electrochemical tracing of hypoxia glycolysis

Not Applicable
Recruiting
Conditions
Breast cancer surgery.
Malignant neoplasm of breast, Breast cancer surgery, Hyperplasia
Registration Number
IRCT20190904044697N1
Lead Sponsor
Iran Nano Fund
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

Patients with obvious breast tumor mass, previously diagnosed with solid mass (DCIS, ILC, IDC...).
Neo-adjuvant cases with or without a wire guide.

Exclusion Criteria

No exclusion regarding patients recruitment

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pathological classification of different breast lesions correlated with current peaks of CDP. Results show meaningful consistency between DIN (Ductal Intraepithelial Neoplasia) based pathological diagnosis and CDP scoring. Timepoint: Results will be compared with permanent pathology about 2 weeks after intervention. Method of measurement: Electrochemical Cyclic voltammetry.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath